Novartis has entered into a multi-year collaboration with Amazon Web Services (AWS) to reimagine its core pharmaceutical manufacturing, supply chain and delivery options using cloud services.
Core to this collaboration is the creation of Novartis ‘Insight Centers’ that provide real-time visibility across its network of manufacturing operations and distribution centres.
Building on the success of its trial operations centre SENSE, these ‘Insight Centers’ can enable manufacturing and planning teams to better forecast and track production lines, detect potential bottlenecks and then make adjustment recommendations to improve accuracy.
Using AWS, Novartis can collect inventory, quality, and production data across its network and apply AWS Internet of Things (IoT), analytics, and machine learning (ML) services to gain greater visibility and help drive efficiencies.
By centralising this data, Novartis data scientists can also experiment with new optimisation models to help ramp up the production of innovative, personalized treatments that are more complex to make.
In addition, Novartis plans to use AWS IoT services to augment and improve visual inspections of its manufacturing sites by generating images that can be analysed using computer vision algorithms to monitor for risks to manufacturing production, such as unplanned downtime or delayed orders.
With this real-time data, Novartis associates can be better equipped to make data-based decisions that help ensure medicines are efficiently produced and distributed to nearly 1 billion patients in 155 countries around the world.
“Using data science and digital technologies to reimagine the way we manufacture medicines is not only at the heart of our transformation, but also core to our ambition to bring innovative medicines to patients faster,” said Bertrand Bodson, Chief Digital Officer at Novartis.